Muckle–Wells syndrome: clinical perspectives

References

• CuissetLJeruIDumontBFrench CAPS study groupMutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in FranceAnn Rheum Dis201170349549921109514
   PubMed Web of Science ®Google Scholar
• HoffmanHMMuellerJLBroideDHWandererAAKolodnerRDMutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndromeNat Genet200129330130511687797
   PubMed Web of Science ®Google Scholar
• TschoppJMartinonFBurnsKNALPs: a novel protein family involved in inflammationNat Rev Mol Cell Biol2003429510412563287
   PubMed Web of Science ®Google Scholar
• TouitouIKoné-PautIAutoinflammatory diseasesBest Pract Res Clin Rheumatol200822581182919028365
   PubMed Web of Science ®Google Scholar
• NeteaMGNold-PetryCANoldMFDifferential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophagesBlood2009113102324233519104081
   PubMed Web of Science ®Google Scholar
• DinarelloCAImmunological and inflammatory functions of the interleukin-1 familyAnnu Rev Immunol20092751955019302047
   PubMed Web of Science ®Google Scholar
• HaverkampMHvan de VosseEGoldbach-ManskyRHollandSMImpaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)Clin Exp Immunol2014177372073124773462
   PubMed Web of Science ®Google Scholar
• MuckleTJWellsMUrticaria, deafness, and amyloidosis: a new heredofamilial syndromeQ J Med19623123524814476827
   PubMedGoogle Scholar
• LevyRGérardLKuemmerle-DeschnerJfor PRINTO and Euro-feverPhenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever RegistryAnn Rheum Dis201574112043204925038238
   PubMed Web of Science ®Google Scholar
• Koné-PautILachmannHJKuemmerle-DeschnerJBCanakinumab in CAPS Study GroupSustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal studyArthritis Res Ther2011136R20222152723
   PubMed Web of Science ®Google Scholar
• LeporeLPaloniGCaorsiRFollow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with AnakinraJ Pediatr2010157231031520472245
   PubMed Web of Science ®Google Scholar
• Almeida de JesusAGoldbach-ManskyRMonogenic autoinflammatory diseases: concept and clinical manifestationsClin Immunol2013147315517423711932
   PubMed Web of Science ®Google Scholar
• MarzanoAVTavecchioSVenturiniMSalaRCalzavara-PintonPGattornoMUrticarial vasculitis and urticarial autoinflammatory syndromesG Ital Dermatol Venereol20151501415025586657
   PubMed Web of Science ®Google Scholar
• HouxLHachullaEKone-PautIMusculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database studyArthritis Rheumatol201567113027303626245507
   PubMed Web of Science ®Google Scholar
• JéruIDuquesnoyPFernandes-AlnemriTMutations in NALP12 cause hereditary periodic fever syndromesProc Natl Acad Sci U S A200810551614161918230725
   PubMed Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBOzenSTyrrellPNDiagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)Ann Rheum Dis201776694294727707729
   PubMed Web of Science ®Google Scholar
• Koné-PautIGaleottiCCurrent treatment recommendations and considerations for cryopyrin-associated periodic syndromeExpert Rev Clin Immunol201511101083109226312542
   PubMed Web of Science ®Google Scholar
• HawkinsPNLachmannHJMcDermottMFInterleukin-1-receptor antagonist in the Muckle-Wells syndromeN Engl J Med2003348252583258412815153
   PubMed Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBTyrrellPNKoetterIEfficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndromeArthritis Rheum201163384084921360513
   PubMed Web of Science ®Google Scholar
• Ter HaarNLachmannHÖzenSPaediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps ProjectsTreatment of autoinflammatory diseases: results from the Eurofever Registry and a literature reviewAnn Rheum Dis201372567868522753383
   PubMed Web of Science ®Google Scholar
• Rossi-SemeranoLFautrelBWendlingDMAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on behalf of CRI (Club Rhumatisme et Inflammation)Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide surveyOrphanet J Rare Dis2015101925758134
   PubMed Web of Science ®Google Scholar
• NevenBMarvilletITerradaCLong-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndromeArthritis Rheum201062125826720039428
   PubMed Web of Science ®Google Scholar
• LachmannHJKone-PautIKuemmerle-DeschnerJBCanakinumab in CAPS Study GroupUse of canakinumab in the cryopyrin-associated periodic syndromeN Engl J Med2009360232416242519494217
   PubMed Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBHachullaECartwrightRTwo-year results from an open label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypesAnn Rheum Dis201170122095210221859692
   PubMed Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBKoitschevATyrrellPNEarly detection of sensorineural hearing loss in Muckle-Wells-syndromePediatr Rheumatol Online J20151314326531310
   PubMed Web of Science ®Google Scholar
• Rodriguez-SmithJLinYCLi TsaiWCerebrospinal fluid cytokines correlate with aseptic meningitis and blood brain barrier function in neonatal-onset multisystem inflammatory disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System InflammationArthritis Rheumatol Epub2017124
   Web of Science ®Google Scholar
• HoffmannHMThroneMLAmarNJEfficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studiesArthritis Rheum20085882443245218668535
   PubMed Web of Science ®Google Scholar
• HoffmannHMThroneMLAmarNJLong-term efficacy and safety profile of rilonacept in the treatment of cryopyrin-associated periodic syndromes: results of a 72-week open-label extension studyClin Ther201234102091210323031624
   PubMed Web of Science ®Google Scholar
• KullenbergTLöfqvistMLeinonenMGoldbach-ManskyROlivecronaHLong-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromesRheumatology (Oxford)20165581499150627143789
   PubMed Web of Science ®Google Scholar
• ChangZSpongCYJesusAAAnakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS)Arthritis Rheumatol201466113227323225223501
   PubMed Web of Science ®Google Scholar
• Paediatric Rheumatology International Trials OrganisationEurofever project Available from: www.printo.it/eurofever/Accessed June 9, 2017
   Google Scholar
• ClinicalTrials.govClinical outcomes and safety: a registry study of Ilaris (Canakinumab) patients (B-Confident) Available from: https://clinicaltrials.gov/ct2/show/NCT01213641Accessed June 9, 2017
   Google Scholar
• TranTAKoné-PautIMarieINinetJCuissetLMeinzerUMuckle-Wells syndrome and male hypofertility: a case seriesSemin Arthritis Rheum201242332733122512814
   PubMed Web of Science ®Google Scholar